Nevro Receives TGA Approval for Senza II(TM) Spinal Cord Stimu...
REDWOOD CITY, California, Sept. 17, 2018 /PRNewswire-AsiaNet/ -- - SUPERIOR THERAPY NOW DELIVERED IN A SMALLER AND MORE REFINED IPGNevro Corp. (NYSE: NVRO), a global medical device company that is providing innovative, evidence-based solutions for the treatment of chronic pain, today announced that it has r...
Read more https://view-release/?pr-id=75229